SMi Systems key facts
as of Oct 2026- Developer of single-molecule discovery and diagnostic tools intended for biomedical research and clinical diagnostics.
- SMi Systems is valued at approximately $52.6M as of Oct 2026 (last reported valuation).
- It has raised $9.5M; the latest was Later Stage VC ($6.6M) in Dec 2025.
- Notable investors include Innovate UK, Norcliffe Capital.
- Status: Privately Held (backing).
SMi Systems's last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch SMi Systems: the Monday email on marks, rounds and moves
SMi Systems funding rounds
No funding rounds for SMi Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs SMi Systems
2SMi Systems valuation
SMi Systems's last reported valuation was $52.6 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
SMi Systems investors
2 investors are on record for SMi Systems, including Innovate UK and Norcliffe Capital.
About SMi Systems
Developer of single-molecule discovery and diagnostic tools intended for biomedical research and clinical diagnostics. The company's automated high-throughput platform uses super-resolution microscopy and data analysis software for multi-omic (DNA, RNA, and protein) and multiplexed molecular detection and quantification, enabling researchers and drug developers to analyze molecular interactions and assess drug-target binding.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2018
- Employees
- 19
- Website
- smisystems.co.uk/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.